Clinical Trials Browser

Phase 2 × INDUSTRY × IT-101 × Clear all

NCT00753740 2020-06-12

Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients.

Phase 2 Withdrawn

Neoplasms, Ovarian Neoplasms

NCT01380769 2020-05-28

A Phase 2 Study of CRLX101(NLG207) in Patients With Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

157 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung

NCT02187302 2020-05-28

CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC)

Phase 2 Completed

Carcinoma, Renal Cell